S
Strata Critical Medical, Inc. (SRTA)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
$5.42
-0.09 (-1.63%)
Market Cap: $492.15M
Last updated: Nov 17, 2026 at 11:06 AM ET
Strata Critical Medical, Inc. (SRTA) Valuation Multiples
Strata Critical Medical (SRTA) trades at 1.7x sales and 1.7x book value. Its forward P/E is 138.9x.
Current Multiples
Its free cash flow yield is 0.1%.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 138.9x |
| Price to sales | 1.7x |
| Price to book | 1.7x |
|---|---|
| PEG | N/A |
| FCF yield | 0.1% |
As of Nov 17, 2026
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SRTA
What is SRTA's forward P/E ratio?
Strata Critical Medical has a forward P/E ratio of 138.9x.
Is SRTA stock overvalued?
GNG's valuation label for SRTA is Undervalued.
What is SRTA's price to sales ratio?
Strata Critical Medical has a price to sales ratio of 1.7x.
SRTA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors